Results 281 to 290 of about 200,281 (336)

Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.

European Heart Journal, 2015
E. Gonzalez-Lopez, M. Gallego-Delgado, Gonzalo Guzzo-Merello, F. J. de Haro-del Moral, M. Cobo-Marcos, C. Robles, B. Bornstein, C. Salas, E. Lara-Pezzi, L. Alonso-Pulpón, P. García-Pavía   +10 more
semanticscholar   +1 more source

Impact of preanalytical delay on the performance of plasma Aβ42, Aβ42/40, p‐tau217, and p‐tau217/Aβ42 in detecting brain amyloidosis in the ALZAN cohort

Alzheimer's &Dementia, Volume 21, Issue 11, November 2025.
Abstract BACKGROUND Alzheimer disease (AD), the leading cause of dementia, has increased interest in the development of blood‐based biomarkers for early diagnosis and monitoring. The plasma amyloid beta (Aβ)42/Aβ40 ratio and phosphorylated tau (p‐tau) isoforms closely align with cerebrospinal fluid and positron emission tomography markers.
Constance Delaby, Audrey Gabelle, Marie Duchiron, Germain Busto, Mehdi Morchikh, Christophe Hirtz, Etienne Mondesert, Jean‐Paul Cristol, Genevieve Barnier‐Figue, Florence Perrein, Cédric Turpinat, Snejana Jurici, Karim Bennys, Sylvain Lehmann   +13 more
wiley   +1 more source

Erratum. Targeted biopsy of the ulnar nerve for amyloidosis with potential implications of a diagnostic and nondiagnostic biopsy: illustrative case. [PDF]

J Neurosurg Case Lessons
Spinner RJ.
europepmc   +1 more source

Frequency of Microvascular Pathology and Hippocampal Atrophy on Magnetic Resonance Imaging in a Community Study of Alzheimer's Disease with Blood‐Based Biomarkers

Annals of Neurology, Volume 98, Issue 5, Page 1027-1043, November 2025.
Objective Blood‐based biomarkers for Alzheimer's disease (AD), representing antemortem indicators of AD pathophysiology, have greatly improved the accuracy of diagnosis. However, these biomarkers may not capture a frequent coincident pathology, such as cerebrovascular disease.
Tamil Iniyan Gunasekaran, Danurys Sanchez, Dolly Reyes‐Dumeyer, Rabel Ventura, Clarissa Morales, Mohamad Alshikho, Annie J. Lee, Rafael A. Lantigua, Yian Gu, Lawrence S. Honig, Badri N. Vardarajan, Adam M. Brickman, Richard Mayeux   +12 more
wiley   +1 more source

Cardiac Amyloidosis: Tribulations and New Frontiers. [PDF]

J Pers Med
Nguyen DM, Ramazani N, Sodhi G, Tak T.
europepmc   +1 more source

Prognostic Implications of Thrombocytopenia in Chinese Patients With Newly Diagnosed Multiple Myeloma

Cancer Medicine, Volume 14, Issue 21, November 2025.
ABSTRACT Background Thrombocytopenia is less common but shows high risk of early mortality in newly diagnosed multiple myeloma (NDMM) patients. In the era of novel agents‐based induction therapy (NAIT), it is unclear whether NAIT can overcome the poor prognosis associated with thrombocytopenia.
Xiaojing Li, Xiaohui Lai, Xiaolin Wang, Qiang Liu, Xin Liu, Luqun Wang, Jun Peng, Ping Chen, Hai Zhou   +8 more
wiley   +1 more source

A Rare Unusually Aggressive Form of Hereditary Transthyretin Amyloidosis. [PDF]

JACC Case Rep
Zhang J, Roth LR, Wees I, Phillips L, Pedretti R, Nguyen P, Saelices L, Grodin JL.   +7 more
europepmc   +1 more source

IgG‐Secreting Lymphoplasmacytic Lymphoma Presenting With Massive Kidney Infiltration

Clinical Case Reports, Volume 13, Issue 11, November 2025.
ABSTRACT Various factors related to lymphoplasmacytic lymphoma (LPL) can lead to kidney complications; however, LPL‐related kidney complications are not as well‐described as those with multiple myeloma. Here, we report a case of IgG‐secreting LPL presenting with acute kidney injury owing to direct tumor infiltration.
Yuichi Nakamura, Yoshihiro Itoh, Tomoyuki Sakamoto, Emi Kakegawa, Yasuhito Terui, Taichi Tarusawa, Tsutomu Inoue, Hirokazu Okada, Keisuke Ishizawa, Taketo Yamada   +9 more
wiley   +1 more source

Oral Amyloidosis Secondary to Tuberculosis in an Adult Patient: A Report of a Rare Case. [PDF]

Cureus
Fumero N, Gamboa MG, Jaimes M, Meza M, Villarroel-Dorrego M.   +4 more
europepmc   +1 more source

Generating MRI‐Derived CSF Proxy‐Markers to Predict and Visualize Alzheimer's Disease Progression

Human Brain Mapping, Volume 46, Issue 16, November 2025.
Deep learning models trained on structural MRI to predict cerebrospinal fluid‐based amyloid and tau concentrations can generate latent representations (MRI‐derived CSF proxy/surrogate markers) that can be subsequently transferred for Alzheimer's disease detection and risk prediction, bypassing noninvasive testing and enabling regional distribution ...
Anees Abrol, Vince D. Calhoun, for the Alzheimer's Disease Neuroimaging Initiative   +2 more
wiley   +1 more source